WORCESTER, Mass.—(BUSINESS WIRE)—Advanced Cell Technology, Inc. (OTCBB: ACTC.PK – News), announced today that their study investigating the feasibility of producing functional, oxygen-carrying red…
MARLBOROUGH, Mass.– Advanced Cell Technology, Inc. (“ACT”; OTCBB:ACTCD), a leader in the field of regenerative medicine, announced today that the US…
Dr. Michael West Transitions to Non-Executive Director LOS ANGELES—(BUSINESS WIRE)—Advanced Cell Technology, Inc. (OTCBB:ACTC – News) today announced the promotion of Dr….
Webcast Scheduled for Monday, August 11, 2014 at 5:00 p.m. Eastern Time MARLBOROUGH, Mass.– Advanced Cell Technology, Inc. (“ACT”; OTCBB:ACTC), a…
Experienced Finance and Operations Executive to Join Company on June 12, 2013 MARLBOROUGH, Mass. — May 23, 2013 – Advanced…
MARLBOROUGH, Mass. – May 16, 2013 – Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of…
Patients with 20/100 Vision Will Now be Eligible for Enrollment, Expanding Patient Base and Potentially Accelerating Pace of Trials MARLBOROUGH,…
Access to Federal Funding Could Accelerate Clinical Development June 11, 2010, WORCESTER, MA – Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC) announced today…
Findings Support Use of ACT’s human embryonic stem cells WORCESTER, MA –February 11, 2010 (PR Newswire). Advanced Cell Technology, Inc….
First-Ever Designation for Treatment Using Embryonic Stem Cells WORCESTER — Advanced Cell Technology, Inc. (OTCBB: ACTC), a biotechnology company applying…